MENU
ALEC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alector (ALEC) Ownership - Who owns Alector?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
244
Web
https://www.alector.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
182.15M
P/E Ratio
N/A
Total Cash
457.2M
Projected Growth
N/A
Total Debt
34.64M
Revenue
61.51M
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
4.67
Total Debt/Equity
N/A
Revenue/Share
0.66 USD as % of share price
Fundamentals
ALEC
Capitalization
182M
P/E Ratio
N/A
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
457M
Total Cash/Share
4.67
Total Debt
34.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.66%
Revenue
61.5M
ROE
N/A
Book Value
119M
P/B Ratio
1.53
Cash Flow
N/A
Earnings
-1.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
3.29
Current Revenue Per Employee
63659.75
Dividends Per Share - Security
N/A
EBITDA
-176.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.66
Shares Held By Institutions
552M
Shares Outstanding - Current
97.9M
Total Liabilities
397M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-76.692
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
244
Web
https://www.alector.com